Cargando…
Long-Term Efficacy and Tolerability of a Medium G’ HA Filler with Tri-Hyal Technology on the Rejuvenation of the Mobile Facial Zone
PURPOSE: Injectable hyaluronic acid-based fillers are commonly used for the correction of skin contour irregularities and to smooth skin depressions formed by volume loss during the aging process. These fillers are particularly efficient to restore perioral skin depressions/wrinkles or to correct to...
Autores principales: | David, Michel, Braccini, Frederic, Garcia, Philippe, Loreto, Frederic, Benadiba, Laurent, Gorj, Mihai, Grand-Vincent, Anne, Rumyantseva Mathey, Elena, Deutsch, Jean-Jacques, Ehlinger, Agnès, Cartier, Hugues, Nadra, Karim, Fanian, Ferial |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351526/ https://www.ncbi.nlm.nih.gov/pubmed/37465030 http://dx.doi.org/10.2147/CCID.S395353 |
Ejemplares similares
-
A prospective multicenter clinical trial evaluating the efficacy and safety of a hyaluronic acid‐based filler with Tri‐Hyal technology in the treatment of lips and the perioral area
por: Ehlinger‐David, Agnès, et al.
Publicado: (2022) -
Evaluation of the Performance and Tolerance of the Combination of an HA-based Filler with Tri-Hyal Technology and a Skin Biorevitalizer on Skin Aging Parameters
por: Fanian, Ferial, et al.
Publicado: (2023) -
Comparative clinical study for the efficacy and safety of two different hyaluronic acid‐based fillers with Tri‐Hyal versus Vycross technology: A long‐term prospective randomized clinical trial
por: Braccini, Frederic, et al.
Publicado: (2022) -
Objective 18-month Comparison of the Tolerability of 2 Dermal Fillers Formulated with Tri-Hyal Technology
por: Trevidic, Patrick, et al.
Publicado: (2020) -
A hyaluronic acid‐based filler reduces lipolysis in human mature adipocytes and maintains adherence and lipid accumulation of long‐term differentiated human preadipocytes
por: Nadra, Karim, et al.
Publicado: (2020)